PCSK9
Sort by:
MonteHeart Imaging & Clinical Lectures
Beyond Statins: State of the Art Treatment for Severe Lipid Disorders
FEATURING
Eugenia Gianos
- 267 views
- December 12, 2024
- 3
Top Ten Topics in Clinical Cardiology 2024
Recommendations for Lipid-Lowering Drugs in Patients with Chronic Coronary Syndrome
FEATURING
Deepak Bhatt
- 136 views
- December 3, 2024
- 1
TCT 2024 Insights
TCT 2024 Insights: Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI
FEATURING
Jennifer Rymer
- 7 views
- November 21, 2024
Right Care Initiative
Intravascular Plaque Anatomic Changes with Lipid Lowering Therapy - Why Optimal Medication Management Matters
FEATURING
Matthew Budoff
- 617 views
- November 15, 2024
- 5
Matthew Budoff
Management of Atherosclerotic Cardiovascular Disease: V-Initiate Study
- 2,103 views
- September 27, 2024
- 10
Novartis Cardiology
Understanding Acquisition and Billing for a Non-Statin Lipid-Lowering Therapy
FEATURING
Bobbi Buell
- 1,343 views
- August 30, 2024
- 6
Novartis Cardiology
Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Therapy: Provider Experiences
- 1,476 views
- August 30, 2024
- 2
Novartis Cardiology
Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowering Therapy
- 1,396 views
- August 30, 2024
- 4
Novartis Cardiology
Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a Real-World Setting
FEATURING
Michael Koren
- 1,504 views
- August 30, 2024
- 9
Novartis Cardiology
Expert Insights on Pivotal Phase 3 and Long-term Trial Data in Primary Hyperlipidemia
FEATURING
Dean G. Karalis,
Merle Myerson
- 1,160 views
- August 30, 2024
- 3
Canadian Collaborative Research Network
VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Patients with ASCVD
FEATURING
Milan Gupta
- 159 views
- August 20, 2024
- 4
Canadian Collaborative Research Network
VICTORION-INITIATE Trial – a Post-Lecture Discussion
FEATURING
Narendra Singh,
Milan Gupta
- 5 views
- August 20, 2024
Georgia Heart Institute
Risk Factor Modification for Inflammation – a Post-Lecture Interview
FEATURING
Angela Taylor,
Arshed Quyyumi
- 9 views
- August 14, 2024
Canadian Collaborative Research Network
A Practical Approach to LDL and TG-Related Risk Management
FEATURING
Robert Hegele
- 710 views
- August 13, 2024
- 2
Canadian Collaborative Research Network
The Post-MI Patient – Should We Liberalize the Use of PCSK9 Inhibitors and Colchicine?
FEATURING
Milan Gupta
- 196 views
- August 13, 2024
Canadian Collaborative Research Network
I Ordered an Lp(a) Level – Now What?
FEATURING
Michelle O'Donoghue
- 4,258 views
- August 13, 2024
- 41
Canadian Collaborative Research Network
Panel Discussion: HFpEF Treatment, Colchicine, and Lp(a) Levels
- 36 views
- August 13, 2024
Society for Cardiovascular Angiography & Interventions (SCAI)
Recent Trial Data and Guideline Recommendations
FEATURING
Faisal Latif
- 29 views
- July 30, 2024
Society for Cardiovascular Angiography & Interventions (SCAI)
PCSK9 Inhibitors, Prior Authorization, and Denial Appeal
FEATURING
Debabrata Mukherjee
- 114 views
- July 30, 2024
Society for Cardiovascular Angiography & Interventions (SCAI)
Addressing Gaps in ASCVD Care: SCAI Secondary Prevention Toolkit
FEATURING
Timir Paul
- 71 views
- July 30, 2024
- 1
Complex Coronary Cases
Panel Discussion: Managing Comorbidities in Complex PCI
- 9 views
- July 23, 2024
Complex Coronary Cases
The Latest in Managing Comorbidities in Complex PCI: LDL-C and Lp(a)
FEATURING
Marc Bonaca
- 282 views
- July 23, 2024
- 4